A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria
Public ClinicalTrials.gov record NCT05528861. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lirentelimab in Adult Subjects With H-1 Antihistamine Refractory Chronic Spontaneous Urticaria
Study identification
- NCT ID
- NCT05528861
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Allakos Inc.
- Industry
- Enrollment
- 127 participants
Conditions and interventions
Conditions
Interventions
- Lirentelimab (AK002) Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 25, 2022
- Primary completion
- Dec 26, 2023
- Completion
- Apr 17, 2024
- Last update posted
- Sep 26, 2024
2022 – 2024
United States locations
- U.S. sites
- 51
- U.S. states
- 27
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allakos Investigational Site 227-024 | Birmingham | Alabama | 35209 | — |
| Allakos Investigational Site 227-068 | Cullman | Alabama | 35058 | — |
| Allakos Investigational Site 227-014 | Phoenix | Arizona | 85021 | — |
| Allakos Investigational Site 227-023 | Scottsdale | Arizona | 85251 | — |
| Allakos Investigational Site 227-058 | Bakersfield | California | 93301 | — |
| Allakos Investigational Site 227-026 | Los Angeles | California | 90025 | — |
| Allakos Investigational Site 227-009 | Los Angeles | California | 90045 | — |
| Allakos Investigational Site 227-011 | Mission Viejo | California | 92691 | — |
| Allakos Investigational Site 227-021 | Santa Monica | California | 90404 | — |
| Allakos Investigational Site 227-031 | Upland | California | 91786 | — |
| Allakos Investigational Site 227-006 | Colorado Springs | Colorado | 80907 | — |
| Allakos Investigational Site 227-036 | Jacksonville | Florida | 32256 | — |
| Allakos Investigational Site 227-062 | Miami | Florida | 33135 | — |
| Allakos Investigational Site 227-041 | Sarasota | Florida | 34239 | — |
| Allakos Investigational Site 227-067 | Tampa | Florida | 33607 | — |
| Allakos Investigational Site 227-005 | Tampa | Florida | 33613 | — |
| Allakos Investigational Site 227-018 | Columbus | Georgia | 31904 | — |
| Allakos Investigational Site 227-045 | Boise | Idaho | 83706 | — |
| Allakos Investigational Site 227-045 | Normal | Illinois | 61761 | — |
| Allakos Investigational Site 227-057 | River Forest | Illinois | 60305 | — |
| Allakos Investigational Site 227-074 | Plainfield | Indiana | 46168 | — |
| Allakos Investigational Site 227-047 | Overland Park | Kansas | 66211 | — |
| Allakos Investigational Site 227-051 | Lexington | Kentucky | 40509 | — |
| Allakos Investigational Site 227-019 | Baltimore | Maryland | 21224 | — |
| Allakos Investigational Site 227-012 | Towson | Maryland | 21204 | — |
| Allakos Investigational Site 227-063 | White Marsh | Maryland | 21162 | — |
| Allakos Investigational Site 227-016 | Boston | Massachusetts | 02111 | — |
| Allakos Investigational Site 227-034 | Ann Arbor | Michigan | 48106 | — |
| Allakos Investigational Site 227-032 | Detroit | Michigan | 48202 | — |
| Allakos Investigational Site 227-070 | Farmington Hills | Michigan | 48346 | — |
| Allakos Investigational Site 227-073 | Dilworth | Minnesota | 56529 | — |
| Allakos Investigational Site 227-052 | Rochester | Minnesota | 55905 | — |
| Allakos Investigational Site 227-008 | St Louis | Missouri | 63141 | — |
| Allakos Investigational Site 227-059 | Missoula | Montana | 59808 | — |
| Allakos Investigational Site 227-022 | Brooklyn | New York | 11203 | — |
| Allakos Investigational Site 227-007 | Great Neck | New York | 11021 | — |
| Allakos Investigational Site 227-002 | Asheville | North Carolina | 28801 | — |
| Allakos Investigational Site 227-013 | Cincinnati | Ohio | 45229 | — |
| Allakos Investigational Site 227-029 | Cincinnati | Ohio | 45236 | — |
| Allakos Investigational Site 227-043 | Columbus | Ohio | 43235 | — |
| Allakos Investigational Site 227-064 | Toledo | Ohio | 43617 | — |
| Allakos Investigational Site 227-060 | Oklahoma City | Oklahoma | 73170 | — |
| Allakos Investigational Site 227-027 | Portland | Oregon | 97223 | — |
| Allakos Investigational Site 227-028 | Hershey | Pennsylvania | 17033 | — |
| Allakos Investigational Site 227-040 | Philadelphia | Pennsylvania | 19103 | — |
| Allakos Investigational Site 227-066 | North Charleston | South Carolina | 29420 | — |
| Allakos Investigational Site 227-055 | Austin | Texas | 78759 | — |
| Allakos Investigational Site 227-049 | El Paso | Texas | 79903 | — |
| Allakos Investigational Site 227-039 | Murray | Utah | 84107 | — |
| Allakos Investigational Site 227-071 | Murray | Utah | 84107 | — |
| Allakos Investigational Site 227-033 | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05528861, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 26, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05528861 live on ClinicalTrials.gov.